BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31952668)

  • 1. Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis.
    Torbica A; Fornaro G; Tarricone R; Drummond MF
    Value Health; 2020 Jan; 23(1):17-24. PubMed ID: 31952668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTA Around the World: Broadening Our Understanding of Cross-Country Differences.
    Torbica A
    Value Health; 2020 Jan; 23(1):1-2. PubMed ID: 31952663
    [No Abstract]   [Full Text] [Related]  

  • 4. The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review.
    Löblová O; Trayanov T; Csanádi M; Ozierański P
    Value Health; 2020 Jan; 23(1):3-9. PubMed ID: 31952670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
    Vreman RA; Mantel-Teeuwisse AK; Hövels AM; Leufkens HGM; Goettsch WG
    Value Health; 2020 Jan; 23(1):10-16. PubMed ID: 31952664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
    Oliva-Moreno J; Puig-Junoy J; Trapero-Bertran M; Epstein D; Pinyol C; Sacristán JA
    Value Health; 2020 Jan; 23(1):25-31. PubMed ID: 31952669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
    Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
    Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency and equity considerations in the preferences of health policy-makers in Israel.
    Shmueli A; Golan O; Paolucci F; Mentzakis E
    Isr J Health Policy Res; 2017; 6():18. PubMed ID: 28373904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the Legitimacy of Tough Choices in Healthcare Reimbursement: Approach and Results of a Citizen Forum in The Netherlands.
    Bijlmakers L; Jansen M; Boer B; van Dijk W; Groenewoud S; Zwaap J; Helderman JK; van Exel J; Baltussen R
    Value Health; 2020 Jan; 23(1):32-38. PubMed ID: 31952671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The which-hunt: assembling health technologies for assessment and rationing.
    Giacomini MK
    J Health Polit Policy Law; 1999 Aug; 24(4):715-58. PubMed ID: 10503155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.
    Baji P; García-Goñi M; Gulácsi L; Mentzakis E; Paolucci F
    Eur J Health Econ; 2016 Sep; 17(7):791-9. PubMed ID: 26296623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of federalism on the healthcare system in terms of efficiency, equity, and cost containment: the case of Switzerland.
    Crivelli L; Salari P
    Dev Health Econ Public Policy; 2014; 12():155-78. PubMed ID: 24864386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluation of Systemic Treatments for Advanced Melanoma: A Systematic Review.
    Gorry C; McCullagh L; Barry M
    Value Health; 2020 Jan; 23(1):52-60. PubMed ID: 31952674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.
    Pichon-Riviere A; Garcia-Marti S; Oortwijn W; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2019 Jan; 35(1):64-68. PubMed ID: 30938278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.
    Dakin H; Gray A
    Med Decis Making; 2018 May; 38(4):476-486. PubMed ID: 29683792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis.
    Rubinstein A; Belizán M; Discacciati V
    Int J Technol Assess Health Care; 2007; 23(2):169-76. PubMed ID: 17493302
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.